Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Laura A Magee, Shirin Namouz-Haddad, Vivien Cao, Gideon Koren & Peter von Dadelszen. (2015) Labetalol for hypertension in pregnancy. Expert Opinion on Drug Safety 14:3, pages 453-461.
Read now
Read now
E. J. Waterman, L. A. Magee, K. I. Lim, A. Skoll, D. Rurak & P. von Dadelszen. (2004) Do Commonly Used Oral Antihypertensives Alter Fetal or Neonatal Heart Rate Characteristics? A Systematic Review. Hypertension in Pregnancy 23:2, pages 155-169.
Read now
Read now
D. J. Cruickshank, A. A. Robertson, D. M. Campbell & I. Macgillivray. (1991) Maternal Obstetric Outcome Measures in A Randomised Controlled Study of Labetalol in the Treatment of Hypertension in Pregnancy. Clinical and Experimental Hypertension. Part B: Hypertension in Pregnancy 10:3, pages 333-344.
Read now
Read now
C. J. Pickles, E. M. Symonds & C. R. Brinkman. (1989) The effect of labetalol versus placebo on arterial pressure and forearm venous tone in women with pregnancy induced hypertension. Clinical and Experimental Hypertension. Part B: Hypertension in Pregnancy 8:2, pages 293-304.
Read now
Read now
Bo Sandström. (1984) Clinical Trials of Adrenergic Antagonists in Pregnancy Hypertension. Acta Obstetricia et Gynecologica Scandinavica 63:sup118, pages 57-60.
Read now
Read now
M. P. Moore & C. W. G. Redman. (1982) The treatment of hypertension in pregnancy. Current Medical Research and Opinion 8:sup1, pages 39-46.
Read now
Read now
Articles from other publishers (49)
Jeffrey N. Bone, Akshdeep Sandhu, Edgardo D. AbalosAsma Khalil, Joel Singer, Sarina Prasad, Shazmeen OmarMarianne Vidler, Peter von Dadelszen & Laura A. Magee. (2022) Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses. Hypertension 79:3, pages 614-628.
Crossref
Crossref
Edgardo Abalos, Lelia Duley, D Wilhelm Steyn & Celina Gialdini. (2018) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2018:10.
Crossref
Crossref
Pablo Zambrano, Mario Suwalsky, Malgorzata Jemiola-Rzeminska & Kazimierz Strzalka. (2018) α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes. Biochemical and Biophysical Research Communications 503:1, pages 209-214.
Crossref
Crossref
LA Magee, P Dadelszen, J Singer, T Lee, E Rey, S Ross, E Asztalos, KE Murphy, J Menzies, J Sanchez, A Gafni, A Gruslin, M Helewa, E Hutton, G Koren, SK Lee, AG Logan, JW Ganzevoort, R Welch, JG Thornton & J‐M Moutquin. (2015) Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG: An International Journal of Obstetrics & Gynaecology 123:7, pages 1143-1151.
Crossref
Crossref
Edgardo Abalos, Lelia Duley & D Wilhelm Steyn. (2014) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Marilyn N. Bulloch & Dana G. Carroll. (2012) When One Drug Affects 2 Patients. Journal of Pharmacy Practice 25:3, pages 352-367.
Crossref
Crossref
Shaba N. Molvi, Shahida Mir, Vikram S. Rana, Farhat Jabeen & A. Rauoof Malik. (2012) Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Archives of Gynecology and Obstetrics 285:6, pages 1553-1562.
Crossref
Crossref
PCM Pasker‐de Jong, GA Zielhuis, MMHJ van Gelder, A Pellegrino, FJM Gabreëls & TKAB Eskes. (2010) Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 117:9, pages 1080-1087.
Crossref
Crossref
Edgardo Abalos, Lelia Duley, D Wilhelm Steyn & David J Henderson-Smart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Laura Magee & Lelia Duley. (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2012:8.
Crossref
Crossref
Peter von Dadelszen & Laura A. Magee. (2002) Fall in Mean Arterial Pressure and Fetal Growth Restriction in Pregnancy Hypertension: An Updated Metaregression Analysis. Journal of Obstetrics and Gynaecology Canada 24:12, pages 941-945.
Crossref
Crossref
Ranjan DeySajid KhanVimal AkhouriJoshua WoottonZahid H. Bajwa. (2008) Labetalol for Prophylactic Treatment of Intractable Migraine During Pregnancy. Headache: The Journal of Head and Face Pain 42:7, pages 642-645.
Crossref
Crossref
E Abalos, L Duley, DW Steyn & DJ Henderson-Smart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Laura A Magee, Shelley B Bull, Gideon Koren & Alexander Logan. (2001) The generalizability of trial data; a comparison of ?-blocker trial participants with a prospective cohort of women taking ?-blockers in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 94:2, pages 205-210.
Crossref
Crossref
Natali A.Y. Chung, D. Gareth Beevers & Gregory Y.H. Lip. (2001) Management of Hypertension in Pregnancy. American Journal of Cardiovascular Drugs 1:4, pages 253-262.
Crossref
Crossref
Laura A. Magee, Einat Elran, Shelley B. Bull, Alexander Logan & Gideon Koren. (2000) Risks and benefits of β-receptor blockers for pregnancy hypertension: overview of the randomized trials. European Journal of Obstetrics & Gynecology and Reproductive Biology 88:1, pages 15-26.
Crossref
Crossref
P von Dadelszen, MP Ornstein, SB Bull, AG Logan, G Koren & LA Magee. (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. The Lancet 355:9198, pages 87-92.
Crossref
Crossref
Joel G. Ray. (1999) The Efficacy and Safety of Beta-Blockers for the Treatment of Hypertension during Pregnancy: What the Trials Can and Cannot Tell Us. Journal SOGC 21:7, pages 670-683.
Crossref
Crossref
John M. Davison, Adrian I. Katz & Marshall D. Lindheimer. 1997. Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
561
603
.
Tarek Z.K. Mahmoud, Steingrimur Bjornsson & Andrew A. Calder. (1993) Labetalol therapy in pregnancy induced hypertension: the effects on fetoplacental circulation and fetal outcome. European Journal of Obstetrics & Gynecology and Reproductive Biology 50:2, pages 109-113.
Crossref
Crossref
D.J. Cruickshank, A.A. Robertson, D.M. Campbell & I. MacGillivray. (1992) Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology 45:1, pages 47-51.
Crossref
Crossref
Rosalie Sagraves & Nancy A. Letassy. 1992. Applied Therapeutics. Applied Therapeutics
1319
1349
.
James Johnston Walker. (1991) Hypertensive Drugs in Pregnancy. Clinics in Perinatology 18:4, pages 845-873.
Crossref
Crossref
John M. Davison, Adrian I. Katz & Marshall D. Lindheimer. 1990. Therapy of Renal Diseases and Related Disorders. Therapy of Renal Diseases and Related Disorders
495
532
.
M. J. Boutroy, P. L. Morselli, G. Bianchetti, J. L. Boutroy, L. P�pin & A. Zipfel. (1990) Betaxolol: a pilot study of its pharmacological and therapeutic properties in pregnancy. European Journal of Clinical Pharmacology 38:6, pages 535-539.
Crossref
Crossref
G. Sponer, W. Bartsch & R. G. Hooper. 1990. Pharmacology of Antihypertensive Therapeutics. Pharmacology of Antihypertensive Therapeutics
131
226
.
C. J. PICKLES, E. M. SYMONDS & F. BROUGHTON PIPKIN. (2005) The fetal outcome in a randomized double‐blind controlled trial of labetalol versus placebo in pregnancy‐induced hypertension. BJOG: An International Journal of Obstetrics & Gynaecology 96:1, pages 38-43.
Crossref
Crossref
John M. Davison. 1989. Drugs, Systemic Diseases, and the Kidney. Drugs, Systemic Diseases, and the Kidney
119
131
.
PIERRE-FRANcOIS PLOUIN, GERARD BREART, FRANcOISE MAILLARD, EMILE PAPIERNIK & JEAN-PIERRE RELIER. (1988) Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology 95:9, pages 868-876.
Crossref
Crossref
William H. Frishman & Michael Chesner. (1988) Beta-adrenergic blockers in pregnancy. American Heart Journal 115:1, pages 147-152.
Crossref
Crossref
D. Russo, A. Dal Canton & V. E. Andreucci. 1988. Management of Renal Hypertension. Management of Renal Hypertension
193
220
.
WF Lubbe. (2012) Hypertension in pregnancy: whom and how to treat.. British Journal of Clinical Pharmacology 24:S1.
Crossref
Crossref
J. Rosenfeld, G. Bott-Kanner, G. Boner, A. Nissenkorn, S. Friedman, J. Ovadia, P. Merlob, S. Reisner, E. Paran, E. Zmora, Y. Biale & V. Insler. (1986) Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. European Journal of Obstetrics & Gynecology and Reproductive Biology 22:4, pages 197-204.
Crossref
Crossref
C. A. Michael. (2008) Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 26:1, pages 26-29.
Crossref
Crossref
Vittorio E. Andreucci, Antonio Dal Canton & Domenico Russo. 1986. The Kidney in Pregnancy. The Kidney in Pregnancy
123
131
.
Raymond P. Naden & Christopher W.G. Redman. (1985) Antihypertensive Drugs in Pregnancy. Clinics in Perinatology 12:3, pages 521-538.
Crossref
Crossref
John S. Horvath, Andrew Korda, Andrew Child, David Henderson‐Smart, Andrew Phippard, Geoffrey G. Duggin, Bruce M. Hall & David J. Tiller. (1985) Hypertension in pregnancy: A study of 142 women presenting before 32 weeks' gestation. Medical Journal of Australia 143:1, pages 19-21.
Crossref
Crossref
C.B. Martin & P.R. Hein. 1985. Drug Therapy During Pregnancy. Drug Therapy During Pregnancy
53
84
.
Maurice Sokolow & Malcolm B. McllroyMaurice Sokolow & Malcolm B. Mcllroy. 1981. Kardiologie. Kardiologie
758
768
.
Thomas F. Ferris. (1984) How Should Hypertension During Pregnancy Be Managed?: An Internist's Approach. Medical Clinics of North America 68:2, pages 491-503.
Crossref
Crossref
John M. Davison, Adrian I. Katz & Marshall D. Lindheimer. 1984. Therapy of Renal Diseases and Related Disorders. Therapy of Renal Diseases and Related Disorders
347
376
.
Barry L. Carter. (2017) Labetalol (Trandate, Glaxo Inc.; Normodyne, Schering Corp.). Drug Intelligence & Clinical Pharmacy 17:10, pages 704-712.
Crossref
Crossref
E. Paul MacCarthy & Saul S. Bloomfield. (2012) Labetalol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses and Adverse Effects. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 3:4, pages 193-217.
Crossref
Crossref
H. Kaulhausen. 1983. Therapie mit Antihypertensiva. Therapie mit Antihypertensiva
178
194
.
B.M. HIBBARD & M. ROSEN. (1982) The Management of Eclampsia. Clinics in Obstetrics and Gynaecology 9:2, pages 297-309.
Crossref
Crossref
BN Prichard & DA Richards. (2012) Comparison of labetalol with other anti‐hypertensive drugs.. British Journal of Clinical Pharmacology 13:S1.
Crossref
Crossref
E. Malcolm Symonds. 1982. Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Hypertensive Cardiovascular Disease: Pathophysiology and Treatment
596
611
.
B. Oosterhuis, M. van den Berg & C.J. van Boxtel. (1981) Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection. Journal of Chromatography B: Biomedical Sciences and Applications 226:1, pages 259-265.
Crossref
Crossref
SIMON M. WOOD & J.D. BLAINEY. (1981) Hypertension and Renal Disease. Clinics in Obstetrics and Gynaecology 8:2, pages 439-453.
Crossref
Crossref